NCT06804824 2026-03-18A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid TumorsVividion Therapeutics, Inc.Phase 1 Recruiting220 enrolled
NCT04185883 2025-10-22Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)AmgenPhase 1 Active not recruiting610 enrolled